OPTUS Pharmaceutical Co., Ltd. (KOSDAQ: 131030)

OPTUS Pharmaceutical Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 10, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	100,311	85,935	101,603	112,144	138,482	128,046
Market Cap Growth	26.34%	-15.42%	-9.40%	-19.02%	8.15%	-10.74%
Enterprise Value	34,465	22,719	41,394	35,907	62,531	62,209
Last Close Price	6210.00	5320.00	6168.81	6533.49	7951.19	7262.88
PE Ratio	9.23	7.51	19.52	10.59	8.90	8.12
PS Ratio	1.22	1.19	1.73	1.96	2.28	2.12
PB Ratio	0.69	0.64	0.82	0.88	1.16	1.19
P/FCF Ratio	9.06	9.43	-25.69	-31.53	11.93	9.83
P/OCF Ratio	8.49	6.91	49.67	15.86	7.94	7.61
EV/Sales Ratio	0.44	0.31	0.71	0.63	1.03	1.03
EV/EBITDA Ratio	2.81	1.83	4.75	2.78	3.60	3.49
EV/EBIT Ratio	4.16	2.78	7.89	3.43	4.22	4.10
EV/FCF Ratio	3.11	2.49	-10.47	-10.10	5.39	4.78
Debt / Equity Ratio	0.01	0.02	0.02	0.00	0.00	0.00
Debt / EBITDA Ratio	0.15	0.17	0.30	0.02	0.03	0.01
Debt / FCF Ratio	0.16	0.23	-0.66	-0.07	0.04	0.01
Asset Turnover	0.53	0.51	0.42	0.42	0.49	0.54
Inventory Turnover	2.67	2.52	2.53	3.00	3.59	4.36
Quick Ratio	6.16	6.00	7.12	7.13	10.08	7.90
Current Ratio	7.26	7.02	8.34	8.00	10.89	9.13
Return on Equity (ROE)	7.71%	8.31%	3.99%	8.04%	12.71%	14.41%
Return on Assets (ROA)	3.54%	3.58%	2.37%	4.85%	7.44%	8.52%
Return on Capital (ROIC)	3.83%	3.88%	2.58%	5.31%	8.14%	9.36%
Earnings Yield	10.83%	12.52%	4.93%	8.82%	10.40%	11.40%
FCF Yield	11.04%	10.60%	-3.89%	-3.17%	8.38%	10.17%
Payout Ratio	14.89%	14.09%	32.01%	16.22%	11.33%	11.18%
Buyback Yield / Dilution	1.41%	4.22%	1.07%	0.62%	1.20%	-0.05%
Total Shareholder Return	1.41%	4.22%	1.07%	0.62%	1.20%	-0.05%

Source: S&P Capital IQ. Standard template. Financial Sources.